Marie-Louise Bots

Marie-Louise Bots is an experienced executive with a robust background in corporate and business development, currently serving as Executive Board Member and SVP Global Corporate & Business Development at Turn Biotechnologies since October 2020. In addition to this role, Marie-Louise holds several key positions including Member of The Supervisory Board Audit Committee at Brabantse Ontwikkelings Maatschappij, Independent Member of the Supervisory Board at Delta Life Science, and Expert Committee Member at Stimulus Programmamanagement. Previous experiences include significant roles such as Independent Member of the Supervisory Board at Plasmacure and Royal Asscher Diamond Company, as well as Chief Commercial Officer at Aon. Marie-Louise has advanced education in leadership and management from renowned institutions including Harvard Business School and Babson College.